Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
Not Confirmed
Not Confirmed
24-26 June, 2025
Europ. Pharma Outsourc...Europ. Pharma Outsourcing
Not Confirmed
Not Confirmed
05-06 June, 2025
Not Confirmed
Not Confirmed
05-06 June, 2025
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
Industry Trade Show
Not Confirmed
24-26 June, 2025
Europ. Pharma Outsourc...Europ. Pharma Outsourcing
Industry Trade Show
Not Confirmed
05-06 June, 2025
Industry Trade Show
Not Confirmed
05-06 June, 2025
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/alchem-nicselect-grants-customers-royalty-free-access-to-t-max-tech-for-3-in-1-vape-satisfaction-in-flavour-restricted-markets
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/excipient-market-overview-roquette-announces-restructuring-post-iff-pharma-buyout-who-fda-advance-regulatory-frameworks
02 Jun 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/06/02/3092136/0/en/OSE-Immunotherapeutics-Provides-Clinical-Updates-on-Neo-Epitope-Based-Cancer-Vaccine-Tedopi-in-Pancreatic-Cancer-and-Non-Small-Cell-Lung-Cancer.html
23 May 2025
// FIERCE BIOTECH
https://www.fiercebiotech.com/biotech/france-invests-eu13m-novel-mrna-project-led-ose-immunotherapeutics
23 May 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/05/23/3087239/0/en/OSE-Immunotherapeutics-Announces-that-its-Partner-Boehringer-Ingelheim-Will-Present-Early-Clinical-Evidence-of-Innate-Immune-Modulation-and-Anti-Tumor-Activity-via-SIRP%CE%B1-Blockade-i.html
05 May 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/05/05/3074333/0/en/OSE-Immunotherapeutics-Announces-90-of-Responders-Maintained-Symptomatic-Remission-Through-Extension-Period-on-Lusvertikimab.html
30 Apr 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/04/30/3070957/0/en/Immuno-Oncology-Results-from-Research-Collaboration-with-L%C3%A9on-B%C3%A9rard-Cancer-Center-Presented-at-AACR-Annual-Meeting-2025.html
23 Apr 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/04/23/3066693/0/en/OSE-Immunotherapeutics-Highlights-Abstracts-Selected-for-Presentation-at-ASCO-2025.html
ABOUT THIS PAGE